The Vanguard Group 13D and 13G filings for Intercept Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-10 11:07 am Sale |
2023-09-29 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
The Vanguard Group | 2,071,222 4.950% |
-2,622,585 (-55.87%) |
Filing |
| 2023-07-10 10:41 am Purchase |
2023-06-30 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
The Vanguard Group | 4,693,807 11.260% |
1,055,872 (+29.02%) |
Filing |
| 2023-02-09 11:22 am Purchase |
2022-12-30 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
The Vanguard Group | 3,637,935 8.780% |
1,666,176 (+84.50%) |
Filing |
| 2022-02-10 08:17 am Sale |
2021-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
The Vanguard Group | 1,971,759 6.670% |
-1,391,318 (-41.37%) |
Filing |
| 2021-06-10 10:06 am Purchase |
2021-05-28 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
The Vanguard Group | 3,363,077 10.140% |
534,122 (+18.88%) |
Filing |
| 2021-02-10 11:03 am Purchase |
2020-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
The Vanguard Group | 2,828,955 8.570% |
532,517 (+23.19%) |
Filing |